<DOC>
	<DOCNO>NCT01709942</DOCNO>
	<brief_summary>In study effectiveness degarelix , long act GnRH antagonist administer unique administration 20 mg first day menstrual cycle , prevent ovarian hyperstimulation syndrome ( OHSS ) PCOS woman risk develop OHSS .</brief_summary>
	<brief_title>Use Degarelix Controlled Ovarian Hyperstimulation ( COH ) Protocol Women With PoliCystic Ovarian Syndrome ( PCOS )</brief_title>
	<detailed_description>Women PCOS risk develop OHSS stimulate gonadotrophin IVF . For reason study degarelix test order minimize risk OHSS well improve pregnancy rate patient . The use long act GnRH antagonist promotes deep suppression LH consequently activity theca cell , secrete androgen ( precursor estradiol ) , consequently level estradiol remain low . Comparing long act GnRH antagonist first day cycle flexible GnRH antagonist protocol group patient PCOS useful order establish best way perform control hyperstimulation IVF cycle minimize risk OHSS .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Cetrorelix</mesh_term>
	<criteria>woman PCOS previous OHSS Infertility 38 year old Body mass index pore 30 systemic disease</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>GnRH antagonist</keyword>
	<keyword>PCOS</keyword>
	<keyword>OHSS</keyword>
	<keyword>COH</keyword>
	<keyword>IVF</keyword>
</DOC>